Trading Summary - March 26. A satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
157
Trading Summary - March 26.

A satisfactory status quo day for $DIGX with the big traders in the OTC off-the-bottom market busy elsewhere.

The usual manipulation attempts were noted - including 7.5M put up as a day trade within the .0004 ask which remained under 20M all day - and the ridiculous almost daily small paint downs of 200 shares and 6,200 shares.

Of course, nobody was duped to sell with the majority of shares in the hands of those who are happy to wait for repeat runs of around 150% from current levels at some point.

The bid was maintained at the usual 36M (visual) all day right up to the close + more in AON orders that are hidden.

Only 5% > 10% of the 584M loaded so far at .0004 are expected to be at .0005.

Asks in the 30M>50M range at each of 2 consecutive levels are relatively easy to deal with on $DIGX as seen on all previous runs.

There is now an limited buying opportunity at .0004 for those that only want 15M but .0005 remains the entry price for those that want to guarantee adding 20M > 50M or more.

As the long-term followers - including at least 5 whales - control the majority of shares bought at .0003/4/5 - and they are not looking to sell anytime soon for less than the market cap - we can expect the "basher" / impatient ask amounts to get taken out at some point - sooner rather than later now.

Watch out for any PR making the excellent performance in the 2017 Annual Report known to the wider investor / trading community.

There should also be an update on the progress of Strategic Growth Plan which includes offering additional services - and hence revenue earning - in each existing office of the chain and acquisition of more already profitable locations to expand the brand.

Beyond that, the PR for the 2018 Q1 Results can be expected by around May 16, 2018 based on the 2017 schedule.

Next update of the Verified Company Profile by the TA - which is expected to again show no dilution whatsoever in 2017 and 2018 to date - should be out within 5-7 business days from now.

As always, anything could happen at anytime. So stay sharp if you don't already have all the shares you need to make your profit expectations on multiple runs up to end-2018 and beyond.

Prior warning and / or scanner alerts of any significant buys starting a run up will not be given on iHub but they will be alerted here immediately.

Content below the line unchanged from the last update - relevant to those that are new here.

The following items have not been PR'ed yet:

- Excellent 2017 Annual Report results - $1.98M Gross Revenue / $234K Net Profit.

- Further acquisition plans for brand growth.

- Shares retired in 2017 (425M known to followers here but not PR'ed yet).

The 2017 results speak for themselves and - when we see them PR'ed to the wider investing community in due course - we may see serious additional new interest due to the low O/S and relatively high positive revenue for a stock in this price range - just as happened for the 2016 Q4 and the 2017 Q1 and Q2.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs throughout 2018. It is already known from posted comments and observation that at least 4 of the main whales bought shares - on the bid and on the ask - from the impatient at the end of 2017.

As predicted, at least 4 x whales who trade $DIGX continuously throughout each year were happy to take around 100M at .0003 when a few impatient people decided to trade for a loss at .0003 on December 14.

As predicted in October 2017, $DIGX was not allowed to go to the 2016 year-end low of .0002 ask at end-2017.

As predicted, the 50M+ .0004s were bought out in just 2 individual seconds and the same is likely to happen with the .0005s.at some point - setting off a run towards .0010 - just like happened in 2017 on a number of occasions.

Any shares bought at .0004 should be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q4. Shares bought at .0005 should easily return 100%+ at some point in 2018.

The big boys in DIGX now probably already have an inventory of 50M>200M each for trading throughout 2018.

Ludicrous claims by the notorious bashers on iHub - "RFB", "munimi", "surfkast:, "Crown Capital" and "Homebrew" - are clearly seen as such by all serious traders and now even by most iHubbers.

Money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.













American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyde Park Hospitality LLC Allegedly Fails to Reimburse Expenses

Updated Category News Views 575

Allegations Against Hyde Park Hospitality LLC Hyde Park Hospitality LLC, a key player in the hospitality industry, is facing serious allegations regarding their reimbursement policies. It has been claimed that the company has not compensated its employees for business-related expenses, including the use of personal cell phones for company duties. This situation raises...

Continue Reading
Miami International Holdings Celebrates Gender Equality in Finance

Updated Category News Views 104

Miami International Holdings Celebrates Gender Equality in Finance Miami International Holdings, Inc. (MIH) proudly participated in a significant event to honor gender equality in the finance sector. The company ceremoniously rang the opening bell at its Princeton, N.J. headquarters, marking its commitment to supporting women in the finance industry. This event aligns...

Continue Reading
Crossject's Capital Raise and New Ventures for ZEPIZURE

Updated Category News Views 202

Crossject Secures Funding for Future Development Crossject, a pioneering specialty pharmaceutical company, has successfully completed a capital increase totaling EUR 7.2 million. This funding comes from the issuance of 3,635,756 shares at a subscription price of EUR 1.6012, equating to about 8.8% of the company's existing share capital. Moreover, the transaction includes...

Continue Reading
Understanding Burford Capital's Upcoming Dividend in GBP

Updated Category News Views 73

Burford Capital's Interim Dividend Announcement Burford Capital Limited, a well-known finance and asset management firm that specializes in law, has announced significant updates regarding its interim dividend. This dividend is an important aspect for investors holding ordinary shares as it directly impacts their returns. Pound Sterling Conversion Rate Details The interim...

Continue Reading
Cole Haan Launches GrandPrø Tennis 2.0 for 21st Century Style

Updated Category News Views 101

Cole Haan Introduces the GrandPrø Tennis 2.0 Cole Haan is excited to reveal the GrandPrø Tennis 2.0, showcasing a new era of style and comfort aimed at modern consumers. This innovative sneaker retains the lightness that the brand is known for while integrating advanced technology for enhanced performance. Revolutionary Features of the GrandPrø Tennis 2.0 The GrandPrø...

Continue Reading